您可时刻接触到最新的关于 Champion Advocates Programme 的必要资源,包括来自我们记者发布会及其他活动的报告。如果您有任何想要分享的新闻,请.(JavaScript must be enabled to view this email address)

The first Global NCD Alliance Forum takes place in Sharjah, UAE, from 13 to 15 November

NewsEvents
对不起,没有您选择的语言版本。显示英文版。

The Global NCD Alliance Forum has been organized under the banner theme of 'NCD Advocacy and Accountability in the Post-2015 Era'. This is an exciting opportunity for representatives to come together for the first time to strengthen the movement and drive progress towards achieving our 25by25 goal. Over two days there will be a mixture of plenary sessions and workshops focusing on three key areas:

  • {st_image_caption}

Emerging Leaders Applications 2015 NOW OPEN

EventsEmerging Leaders Events
对不起,没有您选择的语言版本。显示英文版。

The Emerging Leaders Programme has been created by the World Heart Federation to form and develop a long-term cadre of experts who collaborate, research, and act to reduce premature mortality from cardiovascular disease (CVD) globally by at least 25% by 2025. The programme is supported by unrestricted educational grant from Boehringer Ingelheim. If you are interested in applying, please click here. Applications are accepted from 1st – 30th September.

Join us at the European Society Cardiology Congress 30 August - 3 September, Barcelona, Spain

Events
对不起,没有您选择的语言版本。显示英文版。

Join us at ESC in Barcelona and see how the Champion Advocates programme is making a real difference in how we are looking at the fight against cardiovascular disease. You will find us at stand C200 so please come along and see us.

  • {st_image_caption}

Hamilton, Ontario hosts first Emerging Leaders think tank seminar: Future Leaders in Saving Lives

NewsEvents
对不起,没有您选择的语言版本。显示英文版。

What will it take to avoid millions of preventable cardiovascular disease death? Coordinated action and new ways of working across disciplines and sectors are key. This week saw the inauguration of a group of emerging leaders who are dedicated to making changes to reduce premature mortality from cardiovascular disease (CVD) by 25% by 2025.